Merck Taps PPD as 'Preferred Provider'
For Proteomic Biomarker Discovery
PPD said this week that it has been selected as Merck's "preferred provider" for protein biomarker analysis.
Under the terms of the agreement, PPD will analyze Merck samples with its proprietary proteomic analysis platform to identify candidate biological markers for its therapeutic business.
Additional terms of the agreement were not disclosed.